AMPs are endogenous antibiotics with antimicrobial activities, including α/β-defensins, Reg3s, lysozyme, and lectins, and are involved in intestinal inflammation and bacterial infection (Johnstone & Herzberg, 2022; Mookherjee et al., 2020). This evidence concerns the gene ADSL and bacterial infectious disease.